Impact BioMedical, Inc. (IBO)
4.40
+0.30
(+7.32%)
USD |
NYAM |
Nov 05, 16:00
4.41
+0.01
(+0.23%)
After-Hours: 20:00
Impact BioMedical SG&A Expense (TTM) : 0.349M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.349M |
| March 31, 2026 | 0.006M |
| December 31, 2025 | 0.024M |
| September 30, 2025 | 0.168M |
| June 30, 2025 | 0.627M |
| March 31, 2025 | 0.644M |
| December 31, 2024 | 0.633M |
| September 30, 2024 | 0.609M |
| June 30, 2024 | 0.171M |
| March 31, 2024 | 0.167M |
| December 31, 2023 | 0.199M |
| September 30, 2023 | 0.095M |
| June 30, 2023 | 0.079M |
| March 31, 2023 | 0.094M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.068M |
| September 30, 2022 | 0.058M |
| June 30, 2022 | 0.0792M |
| March 31, 2022 | 0.0506M |
| December 31, 2021 | 0.042M |
| September 30, 2021 | 0.0398M |
| June 30, 2021 | 0.0156M |
| March 31, 2021 | 0.0204M |
| December 31, 2020 | 0.0173M |
| September 30, 2020 | 0.015M |
| June 30, 2020 | 0.011M |
| March 31, 2020 | 0.0058M |
| September 30, 2019 | 0.0035M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 159.82M |
| Enveric Biosciences, Inc. | 6.099M |
| ANI Pharmaceuticals, Inc. | 324.76M |
| Corcept Therapeutics, Inc. | 432.49M |
| Veru, Inc. | 16.05M |